First EU trial begins of Chinese-made biologic

Prima BioMed Ltd. (ASX:PRR; NASDAQ:PBMD) and its manufacturing partner WuXi AppTec Co. Ltd. said a Belgian patient in the Phase

Read the full 201 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE